サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676094

眼科ドラッグデリバリー技術の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Ocular Drug Delivery Technology Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 161 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
眼科ドラッグデリバリー技術の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 161 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

眼科ドラッグデリバリー技術の世界市場規模は、2024年の231億1,000万米ドルから2033年には434億米ドルに成長し、2026～2033年の予測期間中に7.25％の堅調な年間平均成長率（CAGR）を示すと予測されます。

眼科治療の進歩や眼疾患の増加により、革新的なドラッグデリバリーシステムに対する需要が高まっているため、眼科ドラッグデリバリー技術市場は大きく成長する見込みです。ドラッグデリバリー技術は、緑内障、加齢黄斑変性、糖尿病性網膜症など、さまざまな眼疾患に対する治療の有効性とバイオアベイラビリティを高めるように設計されています。高齢化社会と相まって、これらの疾患の発生率が上昇していることが、市場を前進させています。さらに、効果的な眼科治療の重要性に対する認識の高まりが、このセグメントの研究開発を促し、市場の拡大をさらに後押ししています。

技術革新は、眼科ドラッグデリバリー技術市場の将来を形作る上で重要な役割を果たしています。ナノ粒子、ハイドロゲル、埋め込み型デバイスなどの新しいドラッグデリバリーシステムの開発は、眼科治療の精度と有効性を高めています。これらの先進システムは薬剤の徐放を可能にし、投与回数を減らして患者のコンプライアンスを向上させています。さらに、微小電気機械システム（MEMS）やバイオセンサなどのスマート技術の統合により、ドラッグデリバリーや治療結果のリアルタイムモニタリングが可能になりつつあります。これらの技術が進化し続けるにつれて、眼科ドラッグデリバリー市場はさまざまな治療セグメントで採用が拡大するとみられます。

さらに、個別化医療や患者中心のアプローチを重視する傾向が強まっていることも、眼科ドラッグデリバリー技術市場に影響を与えています。医療がオーダーメイド治療にシフトする中、個々の患者のニーズに合わせてカスタマイズできるドラッグデリバリーシステムに対する需要が高まっています。この動向は、副作用を最小限に抑えながら薬効を高める眼科標的治療の開発を促進しています。さらに、規制遵守と安全基準への注目が高まるにつれ、メーカーは産業の要件に沿った先進的ドラッグデリバリー技術への投資を促しています。市場が進化を続ける中、技術、個別化、規制への配慮の統合が成功の重要な促進要因となると考えられます。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます。

市場概要：市場概要：定義、分類、産業の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主要促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の市場開拓と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 OCULARドラッグデリバリー技術産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原料分析
    • 原料リスト
    • 原料メーカー一覧
    • 主要原料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 眼科ドラッグデリバリー技術の世界市場分析：製品タイプ別

  • 製品タイプ別概要
  • 製品タイプ別過去・予測データ分析
  • ゲル
  • 軟膏
  • 点眼薬
  • インサート
  • その他

第6章 眼科ドラッグデリバリー技術の世界市場分析：技術別

  • 技術別概要
  • 技術別過去・予測データ分析
  • ナノ粒子
  • リポソーム
  • ハイドロゲル
  • その他

第7章 眼科ドラッグデリバリー技術の世界市場分析：用途別

  • 用途別概要
  • 用途別過去・予測データ分析
  • 緑内障
  • 糖尿病網膜症
  • 黄斑変性症
  • 白内障
  • その他

第8章 眼科ドラッグデリバリー技術の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • エンドユーザー別過去・予測データ分析
  • 病院
  • 眼科クリニック
  • 在宅医療
  • その他

第9章 眼科ドラッグデリバリー技術の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第10章 眼科ドラッグデリバリー技術企業の競合情勢

  • 眼科ドラッグデリバリー市場競争
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Allergan Inc.
  • Alimera Sciences Inc.
  • Bausch & Lomb Incorporated
  • Novartis AG
  • Regeneron Pharmaceuticals Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Valeant Pharmaceuticals International Inc.
  • Genentech Inc.
  • Pfizer Inc.
  • Johnson & Johnson Vision Care Inc.
  • AbbVie Inc.
  • Sun Pharmaceutical Industries Ltd.
  • EyePoint Pharmaceuticals Inc.
  • Ocular Therapeutix Inc.
  • Kala Pharmaceuticals Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Gels Market Sales By Geography (USD MN)
  • Ointments Market Sales By Geography (USD MN)
  • Eye Drops Market Sales By Geography (USD MN)
  • Inserts Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • Nanoparticles Market Sales By Geography (USD MN)
  • Liposomes Market Sales By Geography (USD MN)
  • Hydrogels Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Glaucoma Market Sales By Geography (USD MN)
  • Diabetic Retinopathy Market Sales By Geography (USD MN)
  • Macular Degeneration Market Sales By Geography (USD MN)
  • Cataract Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Ophthalmic Clinics Market Sales By Geography (USD MN)
  • Homecare Settings Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Ocular Drug Delivery Technology Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Ocular Drug Delivery Technology Report
  • Market Research Process
  • Market Research Methodology
  • Global Ocular Drug Delivery Technology Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Gels Market Sales By Geography (USD MN)
  • Ointments Market Sales By Geography (USD MN)
  • Eye Drops Market Sales By Geography (USD MN)
  • Inserts Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • Nanoparticles Market Sales By Geography (USD MN)
  • Liposomes Market Sales By Geography (USD MN)
  • Hydrogels Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Glaucoma Market Sales By Geography (USD MN)
  • Diabetic Retinopathy Market Sales By Geography (USD MN)
  • Macular Degeneration Market Sales By Geography (USD MN)
  • Cataract Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Ophthalmic Clinics Market Sales By Geography (USD MN)
  • Homecare Settings Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112113039

Global Ocular Drug Delivery Technology Market size is anticipated to grow from USD 23.11 Billion in 2024 to USD 43.4 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.25% during the forecast period of 2026 to 2033.

The Ocular Drug Delivery Technology Market is poised for significant growth as advancements in ophthalmic treatments and the increasing prevalence of eye disorders drive demand for innovative drug delivery systems. Ocular drug delivery technologies are designed to enhance the efficacy and bioavailability of therapeutic agents for various eye conditions, including glaucoma, age-related macular degeneration, and diabetic retinopathy. The rising incidence of these diseases, coupled with an aging population, is propelling the market forward. Additionally, the growing awareness of the importance of effective ocular therapies is encouraging research and development in this field, further boosting market expansion.

Technological innovations are playing a crucial role in shaping the future of the ocular drug delivery technology market. The development of novel drug delivery systems, such as nanoparticles, hydrogels, and implantable devices, is enhancing the precision and effectiveness of ocular therapies. These advanced systems allow for sustained release of medications, reducing the frequency of administration and improving patient compliance. Furthermore, the integration of smart technologies, such as microelectromechanical systems (MEMS) and biosensors, is enabling real-time monitoring of drug delivery and therapeutic outcomes. As these technologies continue to evolve, the ocular drug delivery market is likely to see increased adoption across various therapeutic areas.

Moreover, the growing emphasis on personalized medicine and patient-centric approaches is influencing the ocular drug delivery technology market. As healthcare shifts towards tailored treatments, there is a rising demand for drug delivery systems that can be customized to meet individual patient needs. This trend is driving the development of targeted ocular therapies that enhance drug efficacy while minimizing side effects. Additionally, the increasing focus on regulatory compliance and safety standards is prompting manufacturers to invest in advanced drug delivery technologies that align with industry requirements. As the market continues to evolve, the integration of technology, personalization, and regulatory considerations will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

  • Gels
  • Ointments
  • Eye Drops
  • Inserts
  • Others

By Technology

  • Nanoparticles
  • Liposomes
  • Hydrogels
  • Others

By Application

  • Glaucoma
  • Diabetic Retinopathy
  • Macular Degeneration
  • Cataract
  • Others

By End-User

  • Hospitals
  • Ophthalmic Clinics
  • Homecare Settings
  • Others
  • COMPANIES PROFILED
  • Allergan Inc.
  • Alimera Sciences Inc.
  • Bausch & Lomb Incorporated
  • Novartis AG
  • Regeneron Pharmaceuticals Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Valeant Pharmaceuticals International Inc.
  • Genentech Inc.
  • Pfizer Inc.
  • Johnson & Johnson Vision Care Inc.
  • AbbVie Inc.
  • Sun Pharmaceutical Industries Ltd.
  • EyePoint Pharmaceuticals Inc.
  • Ocular Therapeutix Inc.
  • Kala Pharmaceuticals Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. OCULAR DRUG DELIVERY TECHNOLOGY a€" INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Gels Historic and Forecast Sales By Regions
  • 5.4. Ointments Historic and Forecast Sales By Regions
  • 5.5. Eye Drops Historic and Forecast Sales By Regions
  • 5.6. Inserts Historic and Forecast Sales By Regions
  • 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY TECHNOLOGY

  • 6.1. Overview By Technology
  • 6.2. Historical and Forecast Data Analysis By Technology
  • 6.3. Nanoparticles Historic and Forecast Sales By Regions
  • 6.4. Liposomes Historic and Forecast Sales By Regions
  • 6.5. Hydrogels Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Glaucoma Historic and Forecast Sales By Regions
  • 7.4. Diabetic Retinopathy Historic and Forecast Sales By Regions
  • 7.5. Macular Degeneration Historic and Forecast Sales By Regions
  • 7.6. Cataract Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-User
  • 8.2. Historical and Forecast Data Analysis By End-User
  • 8.3. Hospitals Historic and Forecast Sales By Regions
  • 8.4. Ophthalmic Clinics Historic and Forecast Sales By Regions
  • 8.5. Homecare Settings Historic and Forecast Sales By Regions
  • 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE OCULAR DRUG DELIVERY TECHNOLOGY COMPANIES

  • 10.1. Ocular Drug Delivery Technology Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF OCULAR DRUG DELIVERY TECHNOLOGY INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Allergan Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Alimera Sciences Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Bausch & Lomb Incorporated
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Novartis AG
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Regeneron Pharmaceuticals Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Santen Pharmaceutical Co. Ltd.
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Valeant Pharmaceuticals International Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Genentech Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Pfizer Inc.
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Johnson & Johnson Vision Care Inc.
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. AbbVie Inc.
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Sun Pharmaceutical Industries Ltd.
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. EyePoint Pharmaceuticals Inc.
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Ocular Therapeutix Inc.
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Kala Pharmaceuticals Inc
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies